Roche Holding AG

7 de mai. de 2026, 06:06 UTC

Roche to Buy PathAI for Up to $1.05 Billion to Bolster AI Diagnostics Tools

23 de abr. de 2026, 07:46 UTC

Roche Backs Full-Year View as Quarterly Sales Rise -- Update

23 de abr. de 2026, 05:40 UTC

Roche Backs Full-Year View as Quarterly Sales Rise

9 de mar. de 2026, 16:43 UTC

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study -- Update

9 de mar. de 2026, 15:44 UTC

Correction to Roche Shares Article

9 de mar. de 2026, 09:51 UTC

Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study

6 de mar. de 2026, 09:24 UTC

Zealand Pharma Shares Plunge After Obesity Drug Candidate Disappoints in Trial

13 de mai. de 2026, 10:20 UTC

Roche Strikes Upbeat Tone on Long-Term Outlook -- Market Talk

7 de mai. de 2026, 05:53 UTC

Correct: Roche to Buy PathAI for up to $1.05B

7 de mai. de 2026, 05:07 UTC

Roche: Acquisition Expected to Complete in 2H

7 de mai. de 2026, 05:06 UTC

Roche: Closing of Deal Subject to Customary Closing Conditions

7 de mai. de 2026, 05:06 UTC

Roche to Pay $750M Upfront, Milestone Payments of Up to $300M

7 de mai. de 2026, 05:06 UTC

Roche to Buy PathAI for up to $1.5B

7 de mai. de 2026, 05:05 UTC

Roche to Buy PathAI

6 de mai. de 2026, 22:50 UTC

Sarepta Stock Sinks on Earnings Beat. Elevidys Demand Faces a Reality Check. -- Barrons.com

27 de abr. de 2026, 09:54 UTC

Roche's Vabysmo U.S. Recovery Will Be Key -- Market Talk

23 de abr. de 2026, 08:10 UTC

Roche Reports In Line Sales Figures -- Market Talk

23 de abr. de 2026, 05:04 UTC

Roche Backs 2026 View

23 de abr. de 2026, 05:04 UTC

Roche Diagnostics Division 1Q Sales Up at 3% Constant Currency

23 de abr. de 2026, 05:03 UTC

Roche Pharmaceutical Division 1Q Sales Up 7% at Constant Currency

23 de abr. de 2026, 05:02 UTC

Roche 1Q Group Sales Up 6% at Constant Currency

23 de abr. de 2026, 05:02 UTC

Analysts Saw Roche 1Q Sales at CHF14.73B

23 de abr. de 2026, 05:01 UTC

Roche 1Q Sales CHF14.72B

10 de abr. de 2026, 11:28 UTC

Roche's Longer-Term Outlook to Take Spotlight at Diagnostics Event -- Market Talk

10 de abr. de 2026, 11:17 UTC

Roche to Face Significant Currency Headwinds -- Market Talk

11 de mar. de 2026, 10:57 UTC

Roche Sees Mixed Fortunes in Immunology, Oncology -- Market Talk

9 de mar. de 2026, 09:43 UTC

Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer -- WSJ

6 de mar. de 2026, 07:22 UTC

Roche, Zealand Pharma Obesity Drug Falls Short of Expectations -- Market Talk

3 de mar. de 2026, 07:22 UTC

Roche's Multiple Sclerosis Drug Safety Remains in Focus After Latest Trial -- Market Talk

2 de mar. de 2026, 14:21 UTC

Roche's Multiple Sclerosis Drug Might Not Clear FDA Bar -- Market Talk